S152: COMBINATORY THERAPY OF ASCIMINIB AND PONATINIB WAS EFFECTIVE IN THE TREATMENT OF BLAST PHASE CML CDX MODEL

• Nikola Čuřík,
• Adam Laznicka,
• Vaclava Polivkova,
• Jitka Křížková,
• Pavel Semerak,
• Eva Pokorna,
• Pavla Suchankova,
• Pavel Burda,
• Andreas Hochhaus,
• Kateřina Machová Poláková

Affiliations

Nikola Čuřík

1 Institute of Hematology and Blood Transfusion (ÚHKT), Czech Republic

Adam Laznicka

1 Institute of Hematology and Blood Transfusion (ÚHKT), Czech Republic

Vaclava Polivkova

1 Institute of Hematology and Blood Transfusion (ÚHKT), Czech Republic

Jitka Křížková

1 Institute of Hematology and Blood Transfusion (ÚHKT), Czech Republic

Pavel Semerak

2 2nd Medical School, Charles University, Czech Republic

Eva Pokorna

3 First Faculty of Medicine Charles University, Institute of Pathological Physiology, Czech Republic

Pavla Suchankova

3 First Faculty of Medicine Charles University, Institute of Pathological Physiology, Czech Republic

Pavel Burda

3 First Faculty of Medicine Charles University, Institute of Pathological Physiology, Czech Republic

Andreas Hochhaus

4 Klinik für Innere Medizin II - Hämatologie und Internistische Onkologie, Jena, Germany

Kateřina Machová Poláková

1 Institute of Hematology and Blood Transfusion (ÚHKT), Czech Republic